| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.93▼ | 5.87▲ | 5.89▲ | 5.87▲ | 5.08▲ |
| MA10 | 5.91▲ | 5.90▲ | 5.99▼ | 5.47▲ | 4.86▲ |
| MA20 | 5.89▲ | 5.99▼ | 5.94▼ | 5.13▲ | 4.47▲ |
| MA50 | 5.97▼ | 5.88▲ | 5.66▲ | 4.79▲ | 2.66▲ |
| MA100 | 5.97▼ | 5.57▲ | 5.28▲ | 4.44▲ | 1.92▲ |
| MA200 | 5.86▲ | 5.22▲ | 4.96▲ | 2.92▲ | 5.72▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.011▲ | -0.025▼ | -0.039▼ | 0.111▲ | 0.017▲ |
| RSI | 51.176▲ | 50.083▲ | 53.881▲ | 68.305▲ | 68.898▲ |
| STOCH | 75.702 | 21.617 | 21.998 | 83.380▲ | 62.768 |
| WILL %R | -23.810▲ | -75.000▼ | -68.750 | -19.592▲ | -13.086▲ |
| CCI | 96.068 | -30.354 | -39.870 | 103.173▲ | 235.993▲ |
|
Tuesday, April 14, 2026 05:00 PM
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of ...
|
|
Monday, January 12, 2026 07:16 AM
(RTTNews) - AN2 Therapeutics Inc. (ANTX) announced that the U.S. FDA has cleared its investigator-initiated trial evaluating Epetraborole in 90 patients with Mycobacterium abscessus lung disease, ...
|
|
Sunday, November 09, 2025 04:00 PM
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics through its boron chemistry platform, today announced a collaboration agreement with the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/08/26 | 6.06 | 6.06 | 5.815 | 5.925 | 104,267 |
| 06/08/26 | 5.82 | 6.26 | 5.81 | 6.08 | 207,261 |
| 05/08/26 | 5.94 | 5.99 | 5.71 | 5.84 | 145,950 |
| 04/08/26 | 5.65 | 6.145 | 5.52 | 5.94 | 368,377 |
| 03/08/26 | 5.39 | 5.65 | 5.35 | 5.58 | 305,993 |
| 31/07/26 | 5.37 | 5.66 | 5.26 | 5.35 | 250,627 |
| 30/07/26 | 5.03 | 5.60 | 5.03 | 5.33 | 358,500 |
| 29/07/26 | 4.67 | 5.05 | 4.64 | 5.02 | 181,001 |
| 28/07/26 | 4.92 | 5.10 | 4.63 | 4.70 | 93,811 |
| 27/07/26 | 4.96 | 4.99 | 4.862 | 4.93 | 63,303 |
|
|
||||
|
|
||||
|
|